Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 13.01.2025 3 Intern Med 1 J Autoimmun 1 J Clin Endocrinol Metab 1 J Immunol 5 J Neurol 2 J Pediatr Endocrinol Metab 5 Mult Scler 1 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Intern Med

1. SHIMA T, Iwasaki H, Henzan T, Kato K, et al
   Successful Management of Total Plasma Exchange for Hemolytic Cold Agglutinin Disease.
   Intern Med. 2025;64:119-122.
   PubMed         Abstract available
   
   
2. KAWANO M
   IgG4-related Disease: Recent Topics on Immunological Aspects of This Disorder and Their Application in New Treatment Strategies.
   Intern Med. 2025;64:31-39.
   PubMed         Abstract available
   
   
3. KIRINO Y
   Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.
   Intern Med. 2025;64:25-30.
   PubMed         Abstract available
   
   

   
   J Autoimmun

4. ANDERSEN SS, Neumann TF, Dannesbo S, Raja AA, et al
   Maternal autoimmune systemic connective tissue disease and vasculitis and electrocardiographic findings in the offspring.
   J Autoimmun. 2025;150:103356.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

5. BARTALENA L, Smith TJ
   Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease.
   J Clin Endocrinol Metab. 2025 Jan 9:dgaf009. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   J Immunol

6. PELLERIN A, Tan Y, Lu S, Bonegio RG, et al
   Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic Pathways.
   J Immunol. 2023;211:1308-1319.
   PubMed         Abstract available
   
   

   
   J Neurol

7. SCHUMACHER A, Hieke A, Spenner M, Schmitz F, et al
   Early therapy initiation is crucial in chronic inflammatory demyelinating polyneuropathy: prospective multimodal data from the German INHIBIT registry.
   J Neurol. 2025;272:100.
   PubMed         Abstract available
   
   
8. FILIPPI M, Gallo P, Gasperini C, Marfia GA, et al
   Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome project.
   J Neurol. 2025;272:96.
   PubMed         Abstract available
   
   
9. WALBAUM M, Madhukar A, Dobson R, Cyhlarova E, et al
   Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis.
   J Neurol. 2025;272:93.
   PubMed         Abstract available
   
   
10. FAROOQI AM, Sawalha A, Omidi SJ, Dubey D, et al
    Seizures and status epilepticus in anti-NMDA receptor encephalitis.
    J Neurol. 2025;272:95.
    PubMed         Abstract available
    
    
11. ROBERTSON NP
    Bruton's tyrosine kinase inhibitor for multiple sclerosis: new hope or false dawn.
    J Neurol. 2025;272:106.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

12. GUPTA EA, Huang X, Velasquez HJ, Golani K, et al
    Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2024;38:22-28.
    PubMed         Abstract available
    
    
13. YEWALE S, Chaudhary N, Miriam D, Bhor S, et al
    Geographic information system mapping and predictors of glycemic control in children and youth with type 1 diabetes: a study from Western India.
    J Pediatr Endocrinol Metab. 2024;38:29-36.
    PubMed         Abstract available
    
    

    
    Mult Scler

14. GIOVANNONI G, Boyko A, Correale J, Edan G, et al
    Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort.
    Mult Scler. 2025;31:44-58.
    PubMed         Abstract available
    
    
15. MANISCALCO GT, Dinoto A, Foglia MC, Di Battista ME, et al
    Epstein-Barr virus infection in patients with MOGAD.
    Mult Scler. 2025;31:117-120.
    PubMed         Abstract available
    
    
16. CARNERO CONTENTTI E, Rotstein D, Okuda DT, Paul F, et al
    How to avoid missing a diagnosis of neuromyelitis optica spectrum disorder.
    Mult Scler. 2025;31:8-22.
    PubMed         Abstract available
    
    
17. DEL CANTO A, Carcamo C, Garcia L, Aylwin E, et al
    Real-world evidence of ocrelizumab in Chilean patients with multiple sclerosis.
    Mult Scler. 2025 Jan 6:13524585241309835. doi: 10.1177/13524585241309835.
    PubMed         Abstract available
    
    
18. WITT L, Dost-Kovalsky K, Friedmann N, Bast N, et al
    Ofatumumab-exposed breastfeeding in multiple sclerosis patients.
    Mult Scler. 2025 Jan 6:13524585241307165. doi: 10.1177/13524585241307165.
    PubMed         Abstract available
    
    

    
    Neurology

19. BALCOM EF, Mccombe JA, Kate MP, Vu K, et al
    Inequities in the Use of Disease-Modifying Therapy Among Adults Living With Multiple Sclerosis in Urban and Rural Areas in Alberta, Canada.
    Neurology. 2025;104:e210251.
    PubMed         Abstract available
    
    

    
    PLoS One

20. SIEBALD F, Grittner U, Otto C, Bereuter C, et al
    Ultrasound pupillometry for the detection of a relative afferent pupillary defect (RAPD): Systematic evaluation in patients with optic neuritis and comparison with infrared video pupillometry.
    PLoS One. 2025;20:e0315712.
    PubMed         Abstract available
    
    
21. BIGDELI A, Ghaderi-Zefrehei M, Lesch BJ, Behmanesh M, et al
    Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis.
    PLoS One. 2024;19:e0308817.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.